Cinterion and TZ Medical have announced that Aera-CT, a lightweight and cost-effective heart arrhythmia monitoring device, improves the condition of patients with arrhythmia disorders.
The device is attached to the patient through three electrodes, and monitors for heart arrhythmias during normal day-to-day activities and over long periods of time.
The solution provides patients and physicians with round the clock monitoring, as well as the improved detection and visibility of arrhythmia events.
Peter Fowler, Cinterion’s regional president for the Americas, said that the machine-to-machine heart monitoring technology reduces hospital stays and healthcare costs while improving patient care and ensuring patients’ data privacy.
Related
Aera-CT is expected to be commercially available in North America in Q3 2011.
Related Companies
